Results 261 to 270 of about 6,936,275 (302)
Some of the next articles are maybe not open access.

1D09C3, an mAb specific for MHC-II.

Current opinion in molecular therapeutics, 2008
GPC Biotech AG is developing 1D09C3, an anti-MHC class II (HLA-DR) fully human IgG4 antibody isolated by MorphoSys AG (from its HuCAL library of human antibodies), for the potential treatment of hematological malignancies. In December 2006, positive safety data from two phase I clinical trials were reported. Final phase I data were expected in mid-2007;
Zola, H., Beare, A.
openaire   +2 more sources

Characterization, expression, and polymorphism of MHC II α and MHC II β in Sichuan taimen (Hucho bleekeri)

Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology
The major histocompatibility complex (MHC) is involved in antigen presentation and plays an essential role in regulating immune function. In the present study, we identified two MHC class II genes and investigated their potential roles in Hucho bleekeri. The MHC II α and MHC II β of H.
Yeyu, Chen   +9 more
openaire   +2 more sources

Effects of Exercise on the Macrophage MHC II Response to Inflammation

International Journal of Sports Medicine, 1997
The purpose of this investigation was to determine the effects of different doses of exercise on the ability of Propionibacterium acnes (P. acnes) to induce major histocompatibility complex (MHC) II antigen expression on macrophages (M phi's). Pathogen-free male Balb/c mice were exercised on a treadmill moderately (MOD, 15-17 m/min, 5% grade, 30 min ...
J A, Woods   +3 more
openaire   +2 more sources

Lentiviral Vectors Targeted to MHC II Are Effective in Immunization

Human Gene Therapy, 2010
Viral vectors for vaccination can be optimized by targeting vector entry to antigen-presenting cells (APCs). Here we describe lentiviral vectors (LVs) that are targeted to APC using a chimeric measles virus (MV) hemagglutinin (H). The MV H protein is mutated to prevent binding to MV receptors and incorporates a single-chain antibody that recognizes ...
Alexander, Ageichik   +2 more
openaire   +2 more sources

A protective effect of lower MHC-II expression in MOGAD

Journal of Neuroimmunology
Myelin oligodendrocyte glycoprotein-antibody-associated disease (MOGAD) is a demyelinating central nervous system disorder. We aimed to uncover immune pathways altered in MOGAD to predict disease progression. Using nanostring nCounter technology, we analyzed immune gene expression in PBMCs from MOGAD patients and compare it with healthy controls (HCs).
Ariel, Rechtman   +4 more
openaire   +2 more sources

Rule Induction for Prediction of MHC II-Binding Peptides

2007
Prediction of MHC (Major Histocompatibility Complex) binding peptides is prerequisite for understanding the specificity of T-cell mediated immunity. Most prediction methods hardly acquire understandable knowledge. However, comprehensibility is one of the important requirements of reliable prediction systems of MHC binding peptides.
An Zeng   +3 more
openaire   +2 more sources

MHC II retrograde signaling in MDSC (46.15)

The Journal of Immunology, 2012
Abstract It is now evident that inadequate function of the host immune system is due to suppressive factors such as MDSC. A number of studies demonstrated that MDSC induced antigen-specific tolerance of CD8+, but not CD4+ T cells. In our recent study we found that the ability of MDSC to induce antigen-specific CD4+ T-cell tolerance in ...
Srinivas Nagaraj   +3 more
openaire   +1 more source

Unlock the code of MHC II-enabled Cancer immunotherapy

Critical Reviews in Oncology/Hematology
Major Histocompatibility Complex class II (MHC II) molecules present tumor antigens to CD4 + T cells, playing a pivotal role in initiating anti-cancer immunity. Recent discoveries of MHC II expression on atypical antigen-presenting cells (APCs) have spurred interest in targeting MHC II for immunotherapy.
Jiaqi Liu   +7 more
openaire   +2 more sources

Conformational Lability in MHC II Proteins: A Dissertation

2011
MHC II proteins are heterodimeric glycoproteins that form complexes with antigenic peptides in order to elicit a CD4+ adaptive immune response. Even though there have been numerous MHC II-peptide crystal structures solved, there is little insight into the dynamic process of peptide loading. Through biochemical and biophysical studies, it has been shown
openaire   +2 more sources

Home - About - Disclaimer - Privacy